CARISMA THERAPEUTICS INC (CARM) Stock Cash Flow
NASDAQ:CARM - Nasdaq - US14216R1014 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -50.77M | -60.48M | -86.88M | -19.88M | -340.00K | |||
| Depreciation Amortization | 2.32M | 3.35M | 2.84M | 10.00K | 90.00K | |||
| Change In Working Capital | -7.05M | -11.95M | -5.44M | 63.01M | -48.63M | |||
| Interest Paid | 175.00K | 192.00K | 352.00K | N/A | N/A | |||
| Other non cash items | 7.94M | 9.16M | 8.30M | -18.24M | -20.00M | |||
| OPERATING CASH FLOW | -47.56M | -59.92M | -81.18M | 24.90M | -68.88M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -106.00K | -123.00K | -1.13M | N/A | 0.00 | |||
| Other Investing Activity | 524.00K | 0.00 | 73.54M | -53.97M | N/A | |||
| INVESTING CASH FLOW | 418.00K | -123.00K | 72.41M | -53.97M | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.75M | -2.05M | -1.19M | N/A | N/A | |||
| Stock Issued/Repurchased | 113.00K | 2.40M | 31.42M | 0.00 | 176.13M | |||
| Other Financing Activity | N/A | 0.00 | 31.94M | N/A | 0.00 | |||
| FINANCING CASH FLOW | -1.63M | 344.00K | 62.18M | 0.00 | 176.13M | |||
| CHANGE IN CASH | -48.77M | -59.70M | 53.41M | -29.07M | 107.25M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -47.56M | -59.92M | -81.18M | 24.90M | -68.88M | |||
| Capital Expenditure | -106.00K | -123.00K | -1.13M | N/A | 0.00 | |||
| FREE CASH FLOW | -47.66M | -60.04M | -82.31M | 24.90M | -68.88M | |||
All data in USD